ACTINIUM PHARMACEUTICALS, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 0.85% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2017-03-16
- ACTINIUM PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2016-03-31 was 0.73%, a 17.98% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2015-03-31 was 0.89%, a 32.58% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 1.32%, a 6.45% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 1.24%.
- ACTINIUM PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 0.85%, a 19.81% decline from fiscal 2015.
- ACTINIUM PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2015 was 1.06%, a 3.64% decline from fiscal 2014.
- ACTINIUM PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2014 was 1.10%, a 13.39% decline from fiscal 2013.
- ACTINIUM PHARMACEUTICALS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 1.27%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 1 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | 0.85% 10-K · filed 2017-03-16 | ||||
| 2016-09-30 | 0.59% 10-Q · filed 2016-10-28 | ||||
| 2016-06-30 | 0.52% 10-Q · filed 2016-07-29 | ||||
| 2016-03-31 | 0.73% 10-Q · filed 2016-05-10 | ||||
| 2015-12-31 | 1.06% 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | 0.78% 10-Q · filed 2015-10-30 | ||||
| 2015-06-30 | 0.83% 10-Q · filed 2015-08-07 | ||||
| 2015-03-31 | 0.89% 10-Q · filed 2015-05-08 | ||||
| 2014-12-31 | 1.10% 10-Q · filed 2015-05-08 | 1.10% 10-K · filed 2016-03-11 | |||
| 2014-09-30 | 1.07% 10-Q · filed 2014-10-31 | ||||
| 2014-06-30 | 1.19% 10-Q · filed 2014-08-12 | ||||
| 2014-03-31 | 1.32% 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | 1.27% 10-K · filed 2015-03-16 | ||||
| 2013-09-30 | 0.33% 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | 1.05% 10-Q · filed 2013-08-13 | ||||
| 2013-03-31 | 1.24% 10-Q · filed 2013-05-15 | ||||
| 2012-12-27 | 0.94% 10-K · filed 2014-02-28 | ||||
| 2012-01-31 | 1.24% 10-K · filed 2014-02-28 | ||||
| 2011-12-31 | 1.35% 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |